1. Home
  2. THCH vs VOR Comparison

THCH vs VOR Comparison

Compare THCH & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TH International Limited Ordinary shares

THCH

TH International Limited Ordinary shares

SELL

Current Price

$1.15

Market Cap

32.0M

Sector

Finance

ML Signal

SELL

Logo Vor Biopharma Inc.

VOR

Vor Biopharma Inc.

SELL

Current Price

$19.84

Market Cap

1.1B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
THCH
VOR
Founded
2018
2015
Country
China
United States
Employees
N/A
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.0M
1.1B
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
THCH
VOR
Price
$1.15
$19.84
Analyst Decision
Strong Buy
Analyst Count
0
10
Target Price
N/A
★ $39.00
AVG Volume (30 Days)
14.9K
★ 651.4K
Earning Date
11-23-2026
10-30-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.00
$6.50
52 Week High
$2.70
$26.00

Technical Indicators

Market Signals
Indicator
THCH
VOR
Relative Strength Index (RSI) 48.14 51.86
Support Level $1.07 $17.62
Resistance Level $1.57 $20.11
Average True Range (ATR) 0.14 1.21
MACD 0.01 0.06
Stochastic Oscillator 28.43 48.60

Price Performance

Historical Comparison
THCH
VOR

About THCH TH International Limited Ordinary shares

TH International Ltd is the exclusive master franchisee in China for Tim Hortons, a world-wide coffee and bakery shop brand. Through the Tim Hortons brand, the firm offers freshly brewed coffee, tea, and other beverages, bakery & sides, and sandwiches. The Company operated under a single reportable segment, Tim Hortons. The company's revenue is derived from sales of food, beverages, and packaged products by company-owned and operated stores, franchise fees, and revenue from other franchise support activities. Its geographic revenue is derived from operations in the PRC.

About VOR Vor Biopharma Inc.

Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.

Share on Social Networks: